RHY 1.79% 5.7¢ rhythm biosciences limited

Ann: Appendix 4C, page-5

  1. 30 Posts.
    From what I can gather COLVERA is insufficiently sensitive for use as a screening test for bowel cancer, it is useful in people who are known to have had the cancer to test for recurrence.

    In contrast, as you know, COLOSTAT is designed as a low cost screening tool for the early and accurate detection of colorectal cancers.

    Hopefully it proves to be cheap enough and accurate enough to find an enormous worldwide market!
 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.